MedPath

Safety and Efficacy of Computer Assisted Surgery for Use in Vascular Surgery Procedures

Not Applicable
Terminated
Conditions
Lower Extremity Occlusive Disease
Interventions
Device: Computer assisted surgery
Registration Number
NCT01136811
Lead Sponsor
University of Chicago
Brief Summary

The purpose of this study is to evaluate the preliminary safety and efficacy of the daVinci surgical system (computer-assisted surgery) for use in vascular surgery procedures. Although the daVinci Surgical System is FDA approved and widely used for surgical procedures for urology, cardiac, general, and gynecologic procedures, it is not currently approved specifically for use in vascular surgery and the FDA has required the PI to conduct a small feasibility study under an IDE. The investigators are seeking approval by the FDA to utilize the daVinci Surgical System in vascular surgery and to conduct a future clinical trial.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
11
Inclusion Criteria
  • Patients with significant femoropopliteal or tibial occlusive disease not amenable to catheter directed therapy (ie angioplasty/stenting). Symptoms include lifestyle-limiting claudication, rest pain and/or tissue loss.
  • Patients with an ABI between 0.2 and 0.8.
  • Femoropopliteal disease visible on color duplex ultrasound (DUS)
  • Patent and minimally diseased common femoral and proximal superficial artery
  • Patients with American Society of Anesthesiology (ASA) I, II or III classification
  • PT/PTT, EKG, HbA1c, liver function, within normal ranges within 30 days prior to procedure or stable over the last 6 months.

Current University of Chicago Medical Center Lab standards will be used. Pulmonary function will be assessed as needed by preoperative anesthesia evaluation. (Generally for infrainguinal procedures, pulmonary function is not assessed)

  • Body Mass Index (BMI) <40
Read More
Exclusion Criteria
  • Previous surgery in the inguinal region (ie: prior femoral artery dissection)
  • Myocardial infarction (MI) within the last 6 months
  • Laboratory evidence of hypercoagulable state and/or connective tissue disease
  • Pregnant women
  • History of non-compliance with medical care
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Computer assisted surgeryComputer assisted surgery-
Primary Outcome Measures
NameTimeMethod
Patency of Graft Anastomosis30 Day
Secondary Outcome Measures
NameTimeMethod
Death30day, 1 year

death

Time for Femoral Artery Dissection and Anastomosis1 day
Improvement in ABI Measurement of 0.15 or Better3 month, 6 month, 1 year

Trial Locations

Locations (2)

Weiss Memorial Hospital

🇺🇸

Chicago, Illinois, United States

The University of Chicago

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath